AAV therapy has demonstrated success in treating several disorders, including spinal muscular atrophy (SMA), inherited retinal dystrophies, hemophilia, lysosomal storage disorders, aromatic L-amino acid decarboxylase (AADC) deficiency, and more [69]. This evidence concerns the gene DDC and lysosomal storage disease.